Sponsor Pipeline

Jennifer Amengual Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06954805 Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) Lymphoma Recruiting
Phase 1
NCT07614282 Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia PTLD Not Yet Recruiting
Get alerts when Jennifer Amengual's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free